S Schönwald

761 total citations
25 papers, 507 citations indexed

About

S Schönwald is a scholar working on Epidemiology, Microbiology and Urology. According to data from OpenAlex, S Schönwald has authored 25 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 9 papers in Microbiology and 7 papers in Urology. Recurrent topics in S Schönwald's work include Urinary Tract Infections Management (10 papers), Urinary Bladder and Prostate Research (7 papers) and Reproductive tract infections research (6 papers). S Schönwald is often cited by papers focused on Urinary Tract Infections Management (10 papers), Urinary Bladder and Prostate Research (7 papers) and Reproductive tract infections research (6 papers). S Schönwald collaborates with scholars based in Croatia, Belgium and Slovakia. S Schönwald's co-authors include Višnja Škerk, Ivan Krhen, Josip Čulig, Ilija Kuzman, Leo Markovinović, Srđan Roglić, Adriana Vince, Jasmina Vraneš, Senka Radošević and A. Geddes and has published in prestigious journals such as The American Journal of Medicine, Journal of Antimicrobial Chemotherapy and International Journal of Antimicrobial Agents.

In The Last Decade

S Schönwald

24 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Schönwald Croatia 12 337 131 80 77 74 25 507
W Huck United States 10 252 0.7× 39 0.3× 72 0.9× 34 0.4× 68 0.9× 13 372
Hyun‐Sop Choe South Korea 13 307 0.9× 130 1.0× 93 1.2× 67 0.9× 20 0.3× 33 560
Udo B. Hoyme Germany 13 387 1.1× 210 1.6× 98 1.2× 38 0.5× 60 0.8× 59 622
W R Bowie Canada 14 252 0.7× 261 2.0× 43 0.5× 27 0.4× 142 1.9× 23 576
G. A. Richard United States 11 264 0.8× 40 0.3× 106 1.3× 30 0.4× 77 1.0× 20 431
Višnja Škerk Croatia 11 226 0.7× 132 1.0× 130 1.6× 76 1.0× 30 0.4× 38 415
A Iravani United States 12 379 1.1× 48 0.4× 175 2.2× 25 0.3× 124 1.7× 35 575
Paolo Lanzafame Italy 12 423 1.3× 308 2.4× 115 1.4× 50 0.6× 26 0.4× 20 672
Mary M. Timothy United States 6 377 1.1× 66 0.5× 181 2.3× 30 0.4× 54 0.7× 7 516
Gladys Mihara United States 7 422 1.3× 55 0.4× 173 2.2× 22 0.3× 66 0.9× 8 524

Countries citing papers authored by S Schönwald

Since Specialization
Citations

This map shows the geographic impact of S Schönwald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Schönwald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Schönwald more than expected).

Fields of papers citing papers by S Schönwald

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Schönwald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Schönwald. The network helps show where S Schönwald may publish in the future.

Co-authorship network of co-authors of S Schönwald

This figure shows the co-authorship network connecting the top 25 collaborators of S Schönwald. A scholar is included among the top collaborators of S Schönwald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Schönwald. S Schönwald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Škerk, Višnja, et al.. (2004). The role of unusual pathogens in prostatitis syndrome. International Journal of Antimicrobial Agents. 24. 53–56. 59 indexed citations
3.
Vraneš, Jasmina, et al.. (2003). Virulence Characteristics ofEscherichia coli StrainsCausing Asymptomatic Bacteriuria. Infection. 31(4). 216–220. 14 indexed citations
4.
Škerk, Višnja, et al.. (2002). Aetiology of chronic prostatitis. International Journal of Antimicrobial Agents. 19(6). 471–474. 53 indexed citations
5.
Škerk, Višnja, S Schönwald, Ivan Krhen, et al.. (2002). Comparative Analysis of Azithromycin and Clarithromycin Efficacy and Tolerability in the Treatment of Chronic Prostatitis Caused byChlamydia trachomatis. Journal of Chemotherapy. 14(4). 384–389. 13 indexed citations
6.
Škerk, Višnja, S Schönwald, Ivan Krhen, et al.. (2002). Azithromycin in the Treatment of Chronic prostatitis Caused by Chlamydia trachomatis. 202–202.
7.
8.
Škerk, Višnja, et al.. (2001). [Antimicrobial therapy of urinary tract infections].. PubMed. 123(1-2). 16–25. 2 indexed citations
9.
Vraneš, Jasmina, et al.. (2001). Niska virulencija sojeva Escherichia coli - uzročnika egzarcebacije kroničnog pijelonefritisa. 40(3). 165–170. 3 indexed citations
10.
Škerk, Višnja, et al.. (2001). Azithromycin and doxycycline in the treatment of female patients with acute urethral syndrome caused by Ureaplasma urealyticum: significance of duration of clinical symptoms.. PubMed. 27(4). 135–9. 6 indexed citations
11.
Krčméry, V., J. Jeljaszewicz, Waleria Hryniewicz, et al.. (2000). National and Local Antibiotic Policies in Central and Eastern Europe. Journal of Chemotherapy. 12(6). 471–474. 4 indexed citations
12.
Schönwald, S. (2000). Liječenje spolno prenosivih bolesti. University of Zagreb University Computing Centre (SRCE). 9. 201–207. 1 indexed citations
13.
Schönwald, S, et al.. (1999). Azithromycin: Single 1.5g dose in the treatment of patients with atypical pneumonia syndrome—A randomized study. Infection. 27(3). 198–202. 44 indexed citations
14.
Geddes, A., et al.. (1999). Levofloxacin in the empirical treatment of patients with suspected bacteraemia/sepsis: comparison with imipenem/cilastatin in an open, randomized trial. Journal of Antimicrobial Chemotherapy. 44(6). 799–810. 24 indexed citations
15.
Kuzman, Ilija, et al.. (1996). Azithromycin in the treatment of pneumonias caused by Chlamydia spp: a retrospective study.. PubMed. 16(4-5). 103–7. 3 indexed citations
16.
Kuzman, Ilija, et al.. (1995). Azithromycin for Treatment of Community Acquired Pneumonia Caused by Legionella pneumophila: A Retrospective Study. Scandinavian Journal of Infectious Diseases. 27(5). 503–505. 36 indexed citations
17.
Schönwald, S, et al.. (1994). Three-day Azithromycin Compared with Ten-day Roxithromycin Treatment of Atypical Pneumonia. Scandinavian Journal of Infectious Diseases. 26(6). 706–710. 31 indexed citations
18.
Schönwald, S, et al.. (1991). Comparison of three-day and five-day courses of azithromycin in the treatment of atypical pneumonia. European Journal of Clinical Microbiology & Infectious Diseases. 10(10). 877–880. 60 indexed citations
19.
Schönwald, S, et al.. (1990). Comparison of azithromycin and erythromycin in the treatment of atypical pneumonias. Journal of Antimicrobial Chemotherapy. 25(suppl A). 123–126. 81 indexed citations
20.
Schönwald, S, et al.. (1989). Brief report: Ciprofloxacin in the treatment of gram-negative bacillary meningitis. The American Journal of Medicine. 87(5). S248–S249. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W Huck Breakdown of academic impact, for papers by Hyun‐Sop Choe Breakdown of academic impact, for papers by Udo B. Hoyme Breakdown of academic impact, for papers by W R Bowie Breakdown of academic impact, for papers by G. A. Richard Breakdown of academic impact, for papers by Višnja Škerk Breakdown of academic impact, for papers by A Iravani Breakdown of academic impact, for papers by Paolo Lanzafame Breakdown of academic impact, for papers by Mary M. Timothy Breakdown of academic impact, for papers by Gladys Mihara
Rankless by CCL
2026